Elite Pharmaceuticals (ELTP) Non Operating Interest Expenses (2009 - 2026)
Elite Pharmaceuticals' Non Operating Interest Expenses was $69,749 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 15.4% from $82,470 a year earlier and down 4.6% from the prior quarter.
Elite Pharmaceuticals (ELTP) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Elite Pharmaceuticals' Non Operating Interest Expenses was $780,912 through Sep 30, 2026, up 53.8% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $396,664, down 48.6% from FY2025.
- Non Operating Interest Expenses shows a five-year compound annual growth rate of 8.8% (FY2021 to FY2026).
- In earlier fiscal years, Non Operating Interest Expenses was $772,367 in FY2025 (+31.2%), $588,622 in FY2024 (-47.1%), $1.11 million in FY2023 (+480.1%) and $191,816 in FY2022 (-26.1%).
- Quarterly Non Operating Interest Expenses has moved between -$80,204 (fiscal Q3 2026) and $718,264 (fiscal Q4 2026) over five years.
- Compared with a year earlier, Non Operating Interest Expenses was higher in 1 of the last seven quarters, with growth averaging 8.2%.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was fiscal Q3 2023 (growth of 762.8%); the worst was fiscal Q2 2026 (a decline of 67.7%).
- Per Business Quant data, ELTP's Non Operating Interest Expenses in the three fiscal quarters before Q2 2027 was $73,103 (Q1 2027), $718,264 (Q4 2026) and -$80,204 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn | 69,749.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 69,749.00 |
| Jun 30, 2026 | 73,103.00 |
| Mar 31, 2026 | 718,264.00 |
| Dec 31, 2025 | -80,204.00 |
| Sep 30, 2025 | 82,470.00 |
| Jun 30, 2025 | 158,926.00 |
| Mar 31, 2025 | 188,843.00 |
| Dec 31, 2024 | 77,607.00 |
| Sep 30, 2024 | 255,136.00 |
| Jun 30, 2024 | 250,781.00 |
| Mar 31, 2024 | 217,144.00 |
| Dec 31, 2023 | 121,628.00 |
| Sep 30, 2023 | 130,438.00 |
| Jun 30, 2023 | 119,412.00 |
| Mar 31, 2023 | 330,486.00 |
| Dec 31, 2022 | 322,681.00 |
| Sep 30, 2022 | 242,753.00 |
| Jun 30, 2022 | 216,787.00 |
| Mar 31, 2022 | 65,440.00 |
| Dec 31, 2021 | 37,400.00 |
Elite Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();